25 results
ARS
2024 FY
CCCC
C4 Therapeutics, Inc.
30 Apr 24
Annual report to shareholders
8:52am
supplies. If our current or future suppliers, whether for raw materials, drug substance, or drug product, are unable to supply us with sufficient
ARS
fdt3n6m
28 Apr 23
Annual report to shareholders
7:03am
424B4
xki0x2ji322663 xkl
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
dkbpzab yylqe
19 May 21
Draft registration statement
12:00am
10-K
setqtg9tmyrrt
11 Mar 21
Annual report
4:19pm